Stay on this page and when the timer ends, click 'Continue' to proceed.

Continue in 17 seconds

Ireland

Cosmo Reports Excellent Preliminary Unaudited Full Year 2023 Core Financial Results - Record Guidance for 2024 - Doubles Dividend to 2.00 per Share

Cosmo Reports Excellent Preliminary Unaudited Full Year 2023 Core Financial Results - Record Guidance for 2024 - Doubles Dividend to 2.00 per Share

Source: StreetInsider.com Dublin, Ireland--(Newsfile Corp. - March 20, 2024) - Cosmo Pharmaceuticals N.V. (SIX: COPN) (FSE: C43) (Cosmo) today announced its preliminary unaudited results for the financial year 2023. Financial highlights Cosmo delivered strong growth across its core business in 2023. The company continues to make excellent
InFeed Member
Cosmo Pharmaceuticals N :  reports excellent preliminary unaudited Full Year 2023 core financial results - Record guidance for 2024 - Doubles dividend to € 2.00 per share

Cosmo Pharmaceuticals N : reports excellent preliminary unaudited Full Year 2023 core financial results - Record guidance for 2024 - Doubles dividend to € 2.00 per share

Source: Market Screener Dublin, Ireland - 20 March 2024: Cosmo Pharmaceuticals N.V. (SIX: COPN, XETRA: C43) ("Cosmo") today announced its preliminary unaudited results for the financial year 2023. Financial highlights Cosmo delivered strong growth across its core business in 2023. The company continues to make excellent progress
InFeed Member